Results 161 to 170 of about 384,835 (330)
Esophageal perforation: life threatening complication of endotracheal intubation [PDF]
Jacques Jougon
openalex +1 more source
ABSTRACT Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer, even in patients with liver cirrhosis (LC). Corticosteroids, administered orally or by local injection, are often used to prevent post‐ESD esophageal stricture. However, their safety in patients with decompensated LC and refractory ascites remains unclear. A man
Yuki Tamura +9 more
wiley +1 more source
Distal esophageal perforation caused by tuberculosis [PDF]
Brian C. Grubbs +4 more
openalex +1 more source
Pterodon pubescens Mucoadhesive Film for dental use. ABSTRACT Periodontal diseases involve infectious and inflammatory processes that affect oral tissues. Extracts from Pterodon pubescens Benth (sucupira) have demonstrated antinociceptive, anti‐inflammatory, anti‐edematogenic, and antiplatelet effects, highlighting their therapeutic potential for ...
Mariana Cecchetto Figueiredo +13 more
wiley +1 more source
Esophageal perforation during attempted endotracheal intubation
C Dubost +4 more
openalex +1 more source
Esophageal perforation: a rare complication of Zollinger-Ellison syndrome [PDF]
Thomas Ng +2 more
openalex +1 more source
Tracheoesophageal fistula (TEF), a pathological trachea‐esophagus connection, arises congenitally or from malignancy/radiotherapy/trauma, causing aspiration and malnutrition. Diagnosis utilizes imaging and endoscopy. Treatment ranges from endoscopic stenting to surgical repair and conservative management.
Gang Li +10 more
wiley +1 more source
Pericarditis with effusion complicating esophageal perforation
John R. Hankins, Joseph S. McLaughlin
openalex +1 more source
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source

